Highbridge Capital Management LLC Abb Vie Inc. Transaction History

Highbridge Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $6.36 Million - $7.07 Million	-71,495 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $4.37 Million - $5.17 Million	-48,711 Reduced 40.52%	71,495 $6.62 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $7.3 Million - $9.78 Million	79,348 Added 194.2%	120,206 $11.4 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $2.18 Million - $2.79 Million	31,230 Added 324.37%	40,858 $3.63 Million
Q2 2017 Aug 14, 2017	BUY	N/A	9,628	9,628 $698,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.